Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences. (Q47280327)
Jump to navigation
Jump to search
scientific article published on 9 August 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences. |
scientific article published on 9 August 2012 |
Statements
Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences (English)
Heather E Eve
Sean Carey
Carla C Heise
Vidya Mamidipudi
Tao Shi
Rebecca L Auer
Sheila H Bullard
Simon A J Rule